When will patients in Europe and the UK have access to the newest treatment for pediatric low-grade glioma?

When will the newest treatment for extensive-stage small cell lung cancer be available to patients in Europe (and worldwide)?

When will the new Alzheimer's medicine get its approval? And how long until it gets to your country?

When is the new treatment for melanoma getting its first global approval? Here's what you need to know.

When is Dato dxd's EMA approval expected, and what is the fastest way to access this breast and lung cancer treatment?

When will the latest treatment for multiple myeloma get approval - from the EMA, MHRA, and more?

When will the newest treatment for cutaneous T-cell lymphoma be available in Europe, the UK, and beyond?

When will the new treatment for lung cancer with EGFR and T790M mutations become available in Europe, the UK, and beyond?

When will the newest treatment for low-grade glioma become available - in Europe, the UK, and beyond?

Can lurbinectedin be used to treat Ewing sarcoma and neuroendocrine tumors? The latest data and likely approval timelines.

Relyvrio is being pulled off the market. What does it mean for you and your treatment?

Who qualifies for treatment with lecanemab? And how non-US patients can get the medicine if their doctor prescribes it.

Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?

All you need to know about Ogsiveo (nirogacestat) and what it could mean for your desmoid tumor treatment.

Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.

Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.

When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?

When will Joenja be approved (and available) in Europe and the UK? Including how to avoid waiting.

Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.

When will European patients have access to the newest FDA-approved neuroblastoma treatment?

Iptacopan will soon be approved in Europe, but when will it be available to patients?

Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.

When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.

Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.